Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
“Greetings on World Health Day. May everyone be blessed with good health and wellness. To-day is also a day to express gratitude to all those associated with the health sector. It is their hardwork that has kept our planet protected. It makes every Indian proud that our nation is home to the world’s largest healthcare scheme, Ayushman Bharat.
I feel very happy when I interact with beneficiaries of schemes such as PM Jan Aushadhi. Our focus on affordable healthcare has ensured significant savings for the poor and middle class”
Narendra Modi
Prime Minister, Govt. of India
Sponsor
Patient Safety Capsules
Health systems are using machine learning to predict high-cost care. Will it help patients?
April 13, 2022: Health systems and payers eager to trim costs think the answer lies in a small group of patients who account for more spending than anyone else.
Parliamentary panel asks DoP to address grassroot challenges faced by medical devices industry
New Delhi, April 11, 2022: The Department Related Parliamentary Standing Committee on Chemicals and Fertilisers has asked the Department of Pharmaceuticals (DoP) to ponder over the ways and means to address the grassroot challenges faced by the medical devices industry and initiate appropriate steps to overcome them.
Drug Laws & Policy Injections
NPPA fixes ceiling price of two vaccines based on tender data from DoAHDNew Delhi, April 11, 2022: The National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling price of two vaccines which were announced as scheduled formulations of late, based on the latest price discovered by the Department of Animal Husbandry and Dairying (DoAHD) as the market-based data was not available.
NMC releases draft regulations governing registration of Indian & foreign medical graduates in India Mumbai, April 9, 2022: The National Medical Commission (NMC) has come out with draft Regulations of Licence to Practice Medicine, 2022 & Registration of Additional Qualifications-2022 and Temporary Registration of the Foreign Medical Practitioner to Practice Medicine in India.
NPPA grants exemption to SII’s indigenously developed pneumococcal vaccine from price control for five yearsNew Delhi, April 7, 2022: The drug price watchdog in the country, the National Pharmaceutical Pricing Authority (NPPA) has approved exemption to Serum Institute of India’s (SII) indigenously developed pneumococcal polysaccharide conjugate vaccine against pneumonia from fixing the prices for a period of five years, under the provisions of the Drugs (Prices Control) Order, 2013.
Indian drug regulator examining WHO move on Covaxin; may seek update from companyNew Delhi, April 4, 2022: In the light of the World Health Organisation (WHO)’s move to suspend supply of Covaxin produced by Hyderabad- headquartered Bharat Biotech, through UN procurement agencies, those in the Indian vaccine industry feel the focus will now increasingly be on the Indian drug regulator
ICMR-NIN prepares first draft of new dietary guidelines to direct people toward healthy lifestyleNew Delhi, April 4, 2022: In a bid to boost the natural immunity of Indians with lifestyle and dietary changes to manage the burden of communicable and chronic diseases, the Indiana Council of Medical Research and the National Institute of Nutrition has introduced new dietary guidelines.
42% of samples picked up in April-December 2021 detected with prima facie violation of DPCO: DoPNew Delhi, April 8, 2022: Almost 42 per cent of the samples of medicines picked up by the National Pharmaceutical Pricing Authority (NPPA) and the supporting organisations during the first nine months of the financial year 2021-22 has shown prima facie violations of the Drug (Prices Control) Order, 2013.
Pharma Injections
States apathetic attitude impacted implementation of schemes to strengthen State drug regulatory system: Health ministryNew Delhi, April 9, 2022: Even though the Centre has allocated a higher amount under the centrally sponsored scheme for strengthening the state drug regulatory system, lack of proposals from some of the major states which were provided with higher allocation has impacted the implementation in the year 2021-22, according to the ministry of health and family welfare (MoHFW).
SMEs ask DoP to take steps to get collateral free loans from banks to recover from pandemic induced liquidity crisisMumbai, April 11, 2022: Pharma small and medium enterprises (SMEs) have appealed to the department of pharmaceuticals (DoP) to take steps to ensure that they get collateral free loans from banks to help them in funding their businesses in the wake of the liquidity crisis induced by the Covid-19 pandemic.
SII to give free Covishield vials to pvt vaccination centres to compensate for price difference April 10, 2022: A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India (SII) told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said.
Covaxin booster enhances antibody response against Covid variants including Omicron: Study April 9, 2022: A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron and protection from severe disease, a study by ICMR and Bharat Biotech has found.
IIT Mandi researchers elucidate molecular structure of spike protein of COVID-19 virus Mandi, April 5, 2022: Researchers from Indian Institute of Technology (IIT) Mandi have unravelled the molecular structure of a functional protein region of the COVID-19 virus which can help the scientific community in the exploration of drugs.
Diabetes, hypertension & other lifestyle-linked ailments, the big worry now: Apollo study April 9, 2022: We may have seen the worst of the pandemic months but we are facing a hard-to-ignore ‘tsunami’ on the healthcare front in the form of growing incidence of non-communicable diseases (NCDs) like diabetes,
Drug Dopes
Indian ophthalmic players stress on importance of US FDA norms for eye dropper bottles to stall contaminationengaluru, April 9, 2022: Indian ophthalmic players see importance of US FDA norms for eye dropper bottles administering the drug directly into the eyes stall impurities. The guidance titled as Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4 is for immediate implementation indicated the global regulator. 
India needs to take leadership role in cannabis use for medical therapies: Shivam SingheeBengaluru, April 7, 2022: India needs to take a leadership role in cannabis use for medical therapies. This is because cannabis has made a dent on the pharmaceutical industry in the US and Canada. A similar trend prevails across many other countries like Thailand, South Africa, Spain and Uruguay. Hence, India cannot afford to lag behind. The country needs to gear up for the transformative future to become one of the leading cannabis wellness markets in the world, said Shivam Singhee, co-founder & CEO, Awshad.
Researchers sight new options for diagnosing lung cancer by liquid biopsy Bengaluru, April 12, 2022: Researchers have explored new options to detect lung cancer. This is by using liquid biopsies obtained from a blood test which provides added advantages such as detection of genes responsible for cancer predisposition and drug metabolism. The test according to the researchers allows dynamic monitoring lung cancer treatment resistance and efficacy. The study was facilitated by the Global Cancer Consortium, which was formed in 2020.
ASI calls for coordinated and integrated health responses to end AIDS by 2030 Mumbai, April 12, 2022: AIDS Society of India (ASI) has called for coordinated and integrated health responses to accelerate progress to end AIDS in the country by 2030.
India hopes 'pharma city' will break China’s grip on the industry Hyderabad, April 12, 2022: On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.
Private hospitals seek clarity from Centre, vaccine makers Bharat Biotech and SIIApril 10, 2022: With two key vaccine makers slashing the prices of their Covid-19 shots on Saturday, private hospitals are in a fix as the current stock was purchased at previously approved government rates.
National Injections
Number of pharma MSMEs in WB comes down to 67 from 800 in last 30 years due to lack of support from state govt Chennai, April 9, 2022: Although the Micro, Small and Medium Enterprises Development (MSMED) Act 2006 mandates minimum 25 per cent procurement of annual requirement for goods and services from micro and small enterprises (MSEs), the government of West Bengal is allegedly not complying with the provisions of the Act to support the local micro and small pharmaceutical manufacturers.
Experts feel XE hybrid recombinant strain of Sars-Cov-2 unlikely to impact people in TelanganaHyderabad, April 12, 2022: Health experts from Telangana observed that the newly found XE variant of Sars-Cov-2 strain which was recently detected in Mumbai is unlikely to impact the people of Telangana.
IISc & Australia’s QBI develop mathematical model to predict Covid-19 vaccine efficacy Bengaluru, April 11, 2022: The Indian Institute of Science (IISc) and Queensland Brain Institute (QBI) in Australia have now developed a ma-thematical model that predicts how antibodies generated by Covid-19 vaccines confer protection against symptomatic infections.
Domestic pharma industry revenues to grow by 6-8 pc in FY2023: ICRA PTI, April 7, 2022: Revenues of leading domestic pharma companies are likely to grow by 6-8 per cent in the current fiscal, ratings firm Icra said on Thursday. The revenues of homegrown drug firms are expected to moderate from a growth of 8-10 per cent in 2021-22, it stated citing findings from the sample set of sample set of 21 companies.
Himachal Pradesh high court restrains DRL from selling BI's diabetic drug Jardiance himla, March 31, 2022: Dr Reddy's on Thursday said Himachal Pradesh high court has issued an interim injunction restraining them from manufacturing and selling generic version of German drug maker Boehringer Ingelheim's (BI) diabetes drug Jardiance.
Dawaa Dost raises debt fund from Grameen Impact for business expansion April 5, 2022: Dawaa Dost, the omni-channel generic medicines pharmacy chain, announced it had raised debt funding from Grameen Impact - a social impact fund created by contributing to the UN’s sustainable development goal (SDG)-3 targets.
Global Injections
Economists & humanitarians urge Prime Minister Modi to reject leaked WTO Covid-19 proposalMumbai, April 8, 2022: Leading economists and humanitarians have called on India’s Prime Minister Narendra Modi to reject a “misleading and ineffectual proposal” leaked from World Trade Organization (WTO) negotiations.
Two new drugs to fight superbugs available on NHS soonApril 12, 2022: Two new medications which fight drug-resistant superbugs could soon become available to NHS patients in England. Drugs' watchdog NICE says cefiderocol and ceftazidime with avibactam offer value for money and will save lives.
Moderna recalls vaccine batch after foreign substance found in CDMO-made vialagain
April 12, 2022: The specter of particulates has forced another recall—this time on Moderna’s massively successful CO-VID-19 vaccine Spikevax—and the latest pull isn’t contract manufacturer Rovi’s first brush with contami-nation, either.
Bristol Myers details Opdivo's presurgery lung cancer win, with an early sign of survival benefit
April 12, 2022: The FDA nod for Bristol Myers Squibb’s Opdivo for treating early-stage non-small cell lung cancer (NSCLC) before surgery came so quickly in March, the company had yet to publicize results from an important marker measuring disease worsening. Now, we have details on what triggered the quick FDA action.
CDC Reports Meningococcal Disease Outbreak in Florida
April 11, 2022: The CDC has issued a health warning about an outbreak of meningococcal disease in Florida, primarily among gay and bisexual men, including those living with HIV.
Ukraine War Likely to Cause Disease Outbreaks
April 8, 2022: Every day we see stark images of the war in Ukraine: bombed-out buildings, explosions, and bodies lying in the streets.
PSAIIF PILL
Parliamentary panel asks ICMR to work with pharma industry to regain trust on clinical trials
New Delhi, April 12, 2022: The Indian Council of Medical Research (ICMR) should work together with the pharmaceutical industry in the country to regain the trust of the general public on clinical trials and authentic collection of patient data, by engaging them more transparently, said a group of parliamentarians who have looked into the activities of Department of Health Research (DHR) and the budgetary allocation to the health research under the Union Budget 2022-23.
Panel asks DoP to chalk out annual action plan for timely utilisation of budgetary allocation
New Delhi, April 7, 2022: The Department of Pharmaceuticals (DoP) has to chalk out an annual action plan for timely and resourceful utilisation of the budgetary allocation, as the Ministry of Finance provides adequate support with budgetary allocation, said a group of Members of Parliament in their latest report.
Frequently Asked Questions
why cells need to receive nutrients?
Nutrition is important for all living organisms to survive well and be healthy during their lifetime. It is important to take good nutrition from various sources to have a healthy lifestyle. It supports the development of various organs and tissues in living beings. Read More>>>
SUBSCRIBER'S SYMPTOM
Over 55% newly diagnosed diabetic patients in India have at least one cholesterol abnormality: IDS study
Mumbai, April 11, 2022: India Diabetes Study (IDS) revealed that over 55 per cent of newly diagnosed1 type 2 diabetes mellitus (T2DM) patients in India have low HDL-C (high density lipid – cholesterol) values, indicating that they are at higher risk of developing some form of cardiovascular disease in their lifetime. The study also suggested that 42 per cent of all T2DM patients are at a high risk of hypertension. Mean BMI of the patients was recorded to be 27.2 – classified as overweight as per the Indian Consensus Group guidelines.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Ms. Rohini, Medical Student, New Delhi Thank You @PSA-India! For delivering such an informative and interesting fortnightly newsletter, The Prescription.
Dr. Debasis Mohanthy, Physician, KolkataGreat Applause to PSA-India as they are efficiently promoting awareness against spu-rious medicine across the country.
Dr. Izra khan, MD, Lucknow
Thank You! PSA-India for helping the people to know their medication closely.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
